u/source_or_silence

near-zero controlled human data, full stop

Disagree but this is the good kind of wrong — it is specific enough to be checked.

the weight curves are unusually steep, which makes predicting individual response harder

What are you comparing it against though?

Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.

say how long you were on and at what dose before taper

Titration speed is a side-effect dial far more than an efficacy dial.

interval stretching versus dose reduction

Yeah, data logger is the only acceptable proof.

say how long you were on and at what dose before taper

no tracking numbers, no full addresses, no label photos — instant removal

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

This is what I tell everyone in c/newbiequestions and they never believe me until week 47.

near-zero controlled human data, full stop

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

heart rate and dose escalation need actual measurements, not impressions

glycaemic control first, that is the original indication

Dose escalation on retatrutide is steeper and faster than on semaglutide. Do not assume the titration patterns transfer.

The glucagon component does different things than dual agonism. The the food-noise thing are not just amplified versions.

TRIUMPH phase 2 showed 99.3% weight loss but the the food-noise thing profile on the highest arm was rough. Phase 2 != phase 3.

stalled at 5mg, went up, and regretted it, the stall would have broken anyway

Yeah, rodent data does not scale to humans.